Genetic Variation in H2AFX Contributes to Risk of Non–Hodgkin Lymphoma

Non–Hodgkin lymphoma (NHL) comprises a group of lymphoid tumors that have in common somatic translocations. H2AFX encodes a key histone involved in the detection of the DNA double-stranded breaks that can lead to translocations. H2afx is a dosage-dependent gene that protects against B-cell lymphomas in mice, making its human orthologue an ideal candidate gene for susceptibility to lymphoma. We did a population-based genetic association study of H2AFX variants in 487 NHL cases and 531 controls. Complete resequencing of the human H2AFX gene in 95 NHL cases was done to establish the spectrum of variation in affected individuals; this was followed by both direct and indirect tests for association at the level of individual single nucleotide polymorphisms (SNP) and as haplotypes. Homozygosity for the AA genotype of a SNP 417 bp upstream of the translational start of H2AFX is strongly associated [odds ratio (OR), 0.54; P = 0.001] with protection from NHL. We find a strong association of this SNP with the follicular lymphoma subtype of NHL (AA genotype: OR, 0.40; P = 0.004) and with mantle cell lymphoma (AA genotype: OR, 0.20; P = 0.01) that remains significant after adjustment for the false discovery rate, but not with diffuse large B-cell lymphoma. These data support the hypothesis that genetic variation in the H2AFX gene influences genetic susceptibility or resistance to some subtypes of NHL by contributing to the maintenance of genome stability. (Cancer Epidemiol Biomarkers Prev 2007;16(6):1098–106)

[1]  D. Willerford,et al.  Regulated genomic instability and neoplasia in the lymphoid lineage. , 1999, Blood.

[2]  T. H. Emigh,et al.  A comparison of tests for Hardy-Weinberg equilibrium. , 1980, Biometrics.

[3]  M. Rieder,et al.  Sequence variation in the human angiotensin converting enzyme , 1999, Nature Genetics.

[4]  Frank Dudbridge,et al.  Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.

[5]  Theodore R Holford,et al.  Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. , 2006, The Lancet. Oncology.

[6]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[7]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[8]  E. Boerwinkle,et al.  DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.

[9]  A. Nussenzweig,et al.  DNA damage-induced G2–M checkpoint activation by histone H2AX and 53BP1 , 2002, Nature Cell Biology.

[10]  Daiya Takai,et al.  The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..

[11]  F. Alt,et al.  Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.

[12]  T. Ried,et al.  H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.

[13]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[14]  Adrian Bird,et al.  The essentials of DNA methylation , 1992, Cell.

[15]  Michel C. Nussenzweig,et al.  Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.

[16]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[17]  Jinko Graham,et al.  A Note on Inference of Trait Associations with SNP Haplotypes and Other Attributes in Generalized Linear Models , 2004, Human Heredity.

[18]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[19]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[20]  J. Cerhan,et al.  Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. , 2006, Blood.

[21]  N. E. Breslow.  Statistical Methods in Cancer Research , 1986 .

[22]  W. Doerfler,et al.  DNA methylation and gene activity. , 1983, Annual review of biochemistry.

[23]  Mark Gerstein,et al.  Patterns of nucleotide substitution, insertion and deletion in the human genome inferred from pseudogenes. , 2003, Nucleic acids research.

[24]  Michael M. Murphy,et al.  ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks* , 2001, The Journal of Biological Chemistry.

[25]  K. Begtrup,et al.  Recent increase in the incidence of non-Hodgkin's lymphoma among young men and women in Denmark. , 1996, British Journal of Cancer.

[26]  R. Cartwright.  Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain? , 1992, Cancer research.

[27]  P. Jeggo,et al.  Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination , 2002, Journal of medical genetics.

[28]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[29]  Jeffrey H. Miller,et al.  Mutagenic deamination of cytosine residues in DNA , 1980, Nature.

[30]  A. Bird,et al.  Non‐methylated CpG‐rich islands at the human alpha‐globin locus: implications for evolution of the alpha‐globin pseudogene. , 1987, The EMBO journal.

[31]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..